Jump to content


  • Forum Statistics

    • Total Topics
      6.2k
    • Total Posts
      7.9k
  • Recently Browsing

    • No registered users viewing this page.
  • Posts

    • Rev Assoc Med Bras (1992). 2023 May 29;69(6):e20230256. doi: 10.1590/1806-9282.20230256. eCollection 2023. ABSTRACT OBJECTIVE: We aimed to detect the frequency of fibromyalgia syndrome in patients with rosacea and determine whether this frequency was affected by the severity of rosacea and the quality of life. METHODS: In this prospective, controlled, cross-sectional study, a total of 94 consecutive rosacea cases and 87 age- and sex-matched controls were enrolled. The severity of rosacea was assessed in light of the findings of the National Rosacea Society Ethics Committee. Dermatology Life Quality Index and Rosacea-specific Quality-of-Life instrument had been applied to the cases of rosacea. The diagnosis of fibromyalgia syndrome was established according to the 2016 revised fibromyalgia diagnostic criteria, and the Fibromyalgia Impact Questionnaire was used to determine the functional disability. RESULTS: The frequency of fibromyalgia syndrome was higher in the rosacea group than in the control group (p=0.01), and Dermatology Life Quality Index and Rosacea-specific Quality-of-Life instrument were higher in patients with rosacea with fibromyalgia syndrome (p=0.006 and p=0.004, respectively). A statistically significant weak positive correlation was observed between Dermatology Quality-of-Life Index, Rosacea-specific Quality-of-Life instrument, and Fibromyalgia Impact Questionnaire; symptom severity scale scores; and fibromyalgia score (r=0.35, r=0.259, and r=0.32 and r=0.376, r=0.305, and r=0.312, respectively). CONCLUSION: The patients with rosacea have higher rates and disability scores of fibromyalgia syndrome than healthy controls, independent of rosacea severity, and quality of life is correlated with fibromyalgia scores. We might point out that fibromyalgia syndrome accompanying rosacea has more restrictions in their daily routine activities than rosacea alone. As such, physicians should be aware of the possible coexistence of rosacea and fibromyalgia syndrome. PMID:37255090 | DOI:10.1590/1806-9282.20230256 {url} = URL to article
    • Front Pharmacol. 2023 May 11;14:1169916. doi: 10.3389/fphar.2023.1169916. eCollection 2023. ABSTRACT Background: Antibiotics are considered the backbone of rosacea management, especially for controlling inflammatory papules and pustules. We aim to evaluate the efficacy and safety of varied prescriptions and doses of antibiotics in treating rosacea by network meta-analysis. Methods: In this study, we compared all available randomized controlled trials (RCTs) that have studied systemic and topical antibiotics and placebo in rosacea therapy. We searched databases such as the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, PubMed, Web of Science, and LILACS for published and unpublished RCTs on ClinicalTrials.gov before April 2023. The primary outcome was the improvement of the Investigator's Global Assessment (IGA) scores, and the secondary outcomes consisted of the improvement of the Patient's Global Assessment (PaGA) scores, Clinician's Erythema Assessment (CEA) scores, and adverse events (AEs). We used Bayesian random effects models for multiple treatment comparisons. Results: We identified 1,703 results through these databases. Thirty-one randomized trials with 8,226 patients were included. The heterogeneity and inconsistency between the trials were low, with a low risk of bias of all trials. Oral doxycycline 40 mg, minocycline 100 mg, and minocycline 40 mg, as well as topical ivermectin and metronidazole 0.75%, were effective in treating papules and pustules, thereby decreasing IGA in rosacea. Among these, minocycline 100 mg ranked top in efficacy. As for improving the PaGA scores, topical ivermectin, metronidazole 1%, and systemic oxytetracycline were effective, of which oxytetracycline worked the best. Both doxycycline 40 mg and metronidazole 0.75% presented no therapeutic effect for erythema. Considering the safety of the agents, systemic application of azithromycin and doxycycline 100 mg significantly increase the risk of AEs. Conclusion: Our review suggests that a high dosage of systemic minocycline is the most effective in treating rosacea phenotypes with papules and pustules with a low risk of AEs. However, there were no sufficient evidence-based data in exploring the influence of antibiotics on erythema. The phenotype of rosacea should be taken into consideration along with benefit and safety when making prescriptions due to AEs. Clinical Trial Registration: NCT(2016): http://cochranelibrary-wiley.com/o/cochrane/clcentral/articles/962/CN-01506962/frame.html NCT(2017): http://cochranelibrary-wiley.com/o/cochrane/clcentral/articles/764/CN-01565764/frame.html. PMID:37251342 | PMC:PMC10210163 | DOI:10.3389/fphar.2023.1169916 {url} = URL to article
    • Taiwan J Ophthalmol. 2023 Jan 5;13(1):80-83. doi: 10.4103/tjo.TJO-D-22-00079. eCollection 2023 Jan-Mar. ABSTRACT A 24-year-old woman visited our emergency department due to intermittent dull pain in the right eye, blurred vision, foreign body sensation for 3 weeks, and progressive facial rash with pustules for 3 months. She had a history of recurring skin rash on her face and extremities since early adolescence. Peripheral ulcerative keratitis (PUK) was diagnosed based on slit-lamp examination and corneal topography and then granulomatous rosacea (GR) based on clinical manifestations and skin pathology. Topical prednisolone, artificial tears, oral doxycycline, oral prednisolone, and topical clindamycin were administered. After 1 month, PUK progressed to corneal perforation probably due to eye rubbing. The corneal lesion was repaired with a glycerol-preserved corneal graft. A dermatologist prescribed oral isotretinoin for 2 months in conjunction with topical betamethasone gradually tapered for 14 months. After 34 months of follow-up, no signs of skin and ocular recurrence were noted, and the cornea graft was intact. In conclusion, PUK may present with GR, and oral isotretinoin may be an effective therapy for PUK in the setting of GR. PMID:37252167 | PMC:PMC10220430 | DOI:10.4103/tjo.TJO-D-22-00079 {url} = URL to article
    • Diagnostics (Basel). 2023 May 12;13(10):1718. doi: 10.3390/diagnostics13101718. ABSTRACT Demodex folliculorum and Demodex brevis are commonly present on facial skin and frequently noted via Reflectance Confocal Microscopy (RCM) examination. These mites inhabit follicles and are often seen in groups of two or more, although D. brevis is usually found as a solitary mite. When observed through RCM, they are typically present as refractile, round groupings seen on a transverse image plane inside the sebaceous opening, as they are vertically oriented, and their exoskeletons refract under near-infrared light. Inflammation may occur, leading to a variety of skin disorders; nonetheless, these mites are considered to be part of normal skin flora. a 59-year-old woman presented to our dermatology clinic for confocal imaging (Vivascope 3000, Caliber ID, Rochester, NY, USA) of a previously excised skin cancer for margin evaluation. She did not exhibit symptoms of rosacea or active inflammation of the skin. Incidentally, a solitary demodex mite was noted in a milia cyst nearby the scar. The mite appeared to be trapped in the keratin-filled cyst and was positioned horizontally to the image plane such that its entire body was captured in a coronal orientation as a stack. Demodex identification using RCM can provide clinical diagnostic value in the context of rosacea or inflammation; in our case, this solitary mite was thought to be part of the patient's normal skin flora. Demodex are practically ubiquitous on the facial skin of older patients and are frequently noted during RCM examination; however, the orientation of the mite referenced herein is uncommon, allowing for a unique view of its anatomy. The use of RCM to identify demodex may become more routine as access to technology grows. PMID:37238202 | PMC:PMC10217450 | DOI:10.3390/diagnostics13101718 {url} = URL to article
    • Skin Res Technol. 2023 May;29(5):e13328. doi: 10.1111/srt.13328. ABSTRACT OBJECTIVES: This study aims to introduce compound glycyrrhizin injection for the treatment of rosacea by mesoderm therapy, and further analyze the therapeutic and aesthetic effects of this treatment method and its impact on the dermatological quality of life index, which provides new ideas and methods for cosmetic dermatology treatment of rosacea. METHODS: The recruited rosacea patients were divided into Control group (n = 58) and observation group (n = 58) according to the random number table. The control group was treated with topical metronidazole clindamycin liniment, and the study group was additionally used mesoderm introduction of compound glycyrrhizin injection. The transepidermal water loss (TEWL), water content in corneum, and dermatology life quality index (DLQI) in rosacea patients were evaluated. RESULTS: Our results showed that the scores of erythema, flushing, telangiectasia, and papulopustule were significantly reduced in the observation group. In addition, the observation group significantly decreased TEWL and increased the water content of the stratum corneum. Furthermore, the observation group significantly reduced the DLQI of rosacea patients compared to the control group. CONCLUSION: The use of mesoderm therapy combined with compound glycyrrhizic acid has a therapeutic effect on facial rosacea and improves patient satisfaction. PMID:37231926 | DOI:10.1111/srt.13328 {url} = URL to article
    • Dermatol Clin. 2023 Jul;41(3):377-392. doi: 10.1016/j.det.2023.02.004. Epub 2023 Apr 18. ABSTRACT Identification of specific patterns, shades, and intensity of erythema in the skin has always been critical and fundamental to diagnostic accuracy in dermatology. Erythema is often less noticeable in darker skin types. The interplay of inflammation and variance of skin tone contributes to appreciable differences in the clinical appearance of cutaneous disease in darker complexions. In this article, we discuss common disorders that present with facial erythema in skin of color and offer distinguishing features of each disorder to assist the clinician with diagnosing these conditions in the presence of deeply pigmented skin. PMID:37236708 | DOI:10.1016/j.det.2023.02.004 {url} = URL to article
    • Clin Cosmet Investig Dermatol. 2023 May 18;16:1279-1286. doi: 10.2147/CCID.S414737. eCollection 2023. ABSTRACT BACKGROUND: Abnormal proliferation of Demodex mites causes a skin disorder called demodicosis and has been linked to rosacea. The development of alternative therapy against Demodex mites is currently required. The ability to kill Demodex mites of Thai herbal essential oils has never been explored. This study aimed to study and compare the in vitro killing effect of Thai herbal essential oils, tea tree oil, and metronidazole 0.75% with ivermectin 1% on D. folliculorum. MATERIALS AND METHODS: D. folliculorum mites were collected from the wastes of diagnostic standardized skin surface biopsy samples of demodicosis and rosacea patients for the trial. The microscopic evaluation started immediately after the mites were exposed to immersion oil (negative control), Thai herbal essential oils, tea tree oil, metronidazole 0.75%, and ivermectin 1% (positive control). The survival times of ten mites from each test agent were compared. RESULTS: The efficacy of Thai herbal essential oils and other test agents can be arranged in order as follows: lemongrass oil > sweet basil oil > clove oil > tea tree oil > lesser galangal oil > ginger oil, kaffir lime oil, peppermint oil > citronella oil > galangal oil > cajeput oil > ivermectin 1% > metronidazole 0.75%. CONCLUSION: This current study demonstrated the in vitro killing efficacy on D. folliculorum: Thai herbal essential oils, Tea tree oil > ivermectin 1% > metronidazole 0.75%. Thai herbal essential oils have the potential to be an adjuvant or alternative therapy against Demodex mites. Further in vivo studies are necessary to determine the treatment efficacy and side effects. PMID:37228784 | PMC:PMC10202699 | DOI:10.2147/CCID.S414737 {url} = URL to article
    • Most, if not all of the rosacea research being done is being funded by pharmaceutical companies or what is called the skin industry who have a vested interest in rosacea. The only non profit organizations for rosacea doing any rosacea research are the NRS and the AARS (possibly others) who clearly state that on their financial reports that they are heavily funded by pharmaceutical companies that offers rosacea drug treatments. These non profits as well any just about all rosacea research is funded by the skin industry.  The skin industry includes not only pharmaceutical companies that offer rosacea treatments but also the cosmetic companies that offer over the counter treatments for rosacea.  Science is assumed to be researched in integrity, after all it is science. "Science is a systematic endeavor that builds and organizes knowledge in the form of testable explanations and predictions about the universe." [1] Research is the "creative and systematic work undertaken to increase the stock of knowledge". [2] Integrity is "the practice of being honest and showing a consistent and uncompromising adherence to strong moral and ethical principles and values." [3] While most science research is without question done in integrity, there is a small unknown percentage of dark science worth investigating that results in retractable published research papers due to fraud or other data misinformation. [4]  The Rosacea Research & Development Institute [RRDi] was formed for the purpose of engaging in novel rosacea research that rosacea sufferers want done which is totally in contrast to the current rosacea research being done by the skin industry. For example, if 10K members of the RRDi each donated a dollar and decided what should be researched on rosacea, this non profit organization could actually engage in a different direction than how the skin industry does their research for their own agenda.  While we appreciate any rosacea research being done, it would be incredible if enough rosaceans got together and actually funded their own rosacea research. Are you in? Join the RRDi.  End Notes [1] Science, Wikipedia [2] Research, Wikipedia [3] Integrity, Wikipedia [4] The Truth Police, BBC
    • JAAD Case Rep. 2023 Apr 11;36:32-33. doi: 10.1016/j.jdcr.2023.03.022. eCollection 2023 Jun. NO ABSTRACT PMID:37215297 | PMC:PMC10195851 | DOI:10.1016/j.jdcr.2023.03.022 {url} = URL to article
    • Int J Dermatol. 2023 May 22. doi: 10.1111/ijd.16717. Online ahead of print. ABSTRACT BACKGROUND: Facial erythema in rosacea is a troublesome embarrassing presentation with limited options of treatment. Daily brimonidine gel was shown to be an effective modality of treatment. Being unavailable in Egypt and the scarcity of objective evaluation of its therapeutic effect motivated the search for other alternatives. OBJECTIVE: To evaluate the use and effectiveness of topical brimonidine eye drops for the management of facial erythema in rosacea with the aid of objective assessment. METHODS: The study was conducted on 10 rosacea patients presented with facial erythema. Brimonidine tartrate eye drops 0.2% were applied twice daily for 3 months on areas of red facial skin. Punch biopsies were obtained before and after 3 months of treatment. Routine hematoxylin and eosin (H&E) staining as well as CD34 immunohistochemical staining were performed for all biopsies. Sections were examined to detect the changes in the count and the surface area of blood vessels. RESULTS: Evaluation of clinical results showed good improvement of facial redness at the end of treatment (55-75%). Only 10% of subjects expressed rebound erythema. H&E and CD34 stained sections showed an increased count of dilated dermal blood vessels, which decreased significantly after treatment in count and surface area (P = 0.005, and P = 0.004, respectively). CONCLUSION: Topical brimonidine eye drops proved to be effective in managing facial erythema in rosacea, providing an available and cheaper alternative to brimonidine gel. The study improved the subjective evaluation in the context of objective assessment of treatment efficacy. PMID:37212604 | DOI:10.1111/ijd.16717 {url} = URL to article
    • Front Public Health. 2023 May 3;11:1096687. doi: 10.3389/fpubh.2023.1096687. eCollection 2023. ABSTRACT BACKGROUND: The associations between single risk factors and incident rosacea have been reported, but the effects of social risk factors from multiple domains coupled remain less studied. OBJECTIVES: To quantify the influence of social determinants on rosacea comprehensively and investigate associations between the polysocial risk score (PsRS) with the risks of incident rosacea. METHODS: This was a prospective cohort study of government employees undertaken from January 2018 to December 2021 among participants aged >20 from five cities in Hunan province of China. At baseline, information was collected by a questionnaire and participants were involved in an examination of the skin. Dermatologists with certification confirmed the diagnosis of rosacea. The skin health status of participants was reassessed every year since the enrolment of study during the follow-up period. The PsRS was determined using the nine social determinants of health from three social risk domains (namely socioeconomic status, psychosocial factors, and living environment). Incident rosacea was estimated using binary logistic regression models adjusted for possible confounding variables. RESULTS: Among the 3,773 participants who completed at least two consecutive skin examinations, there were 2,993 participants included in the primary analyses. With 7,457 person-years of total follow-up, we detected 69 incident rosacea cases. After adjustment for major confounders, participants in the group with high social risk had significantly raised risks of incident rosacea with the adjusted odds ratio (aOR) being 2.42 (95% CI 1.06, 5.55), compared to those in low social risk group. CONCLUSION: Our findings suggest that a higher PsRS was associated with an elevated risk of incident rosacea in our study population. PMID:37206873 | PMC:PMC10191232 | DOI:10.3389/fpubh.2023.1096687 {url} = URL to article
    • Adv Biomed Res. 2023 Mar 28;12:72. doi: 10.4103/abr.abr_233_21. eCollection 2023. ABSTRACT BACKGROUND: Rosacea is a skin chronic inflammation with an unknown cause and cure. Environmental and genetic factors could not entirely explain the disease pathogenesis. Recently, infections like Chlamydia pneumoniae are of more attention in the rosacea progression. This study investigated the relationship between the C. pneumoniae seropositivity and the rosacea disorder. MATERIALS AND METHODS: We aimed at a cohort of 100 patients with the rosacea disorder (60 active and 40 inactive) and from 100 sex- and age-matched healthy controls in Isfahan and determined the immunoglobulin M (IgM)/IgG antibodies titers to C. pneumoniae in the serum using the enzyme-linked immunosorbent assay method. The groups were compared using the analysis of variance procedure at the significant level of P < 0.05, statistically. RESULTS: The mean of IgG in the controls was significantly higher than the levels in both the active and the inactive rosacea patients (p < 0.022). Also, the titer of serum IgM to C. pneumoniae in the controls was different, compared with the active (p < 0.019) and the inactive (p < 0.02) rosacea patients. In addition, the median titer of serum IgG (not IgM) to C. pneumoniae in the females with the inactive rosacea disorder was lower than the active rosacea disorder (p < 0.019) and controls women (p < 0.008). Furthermore, the serum level of IgG or IgM to C. pneumoniae in the controls males was higher than the males with the rosacea disorder (p < 0.05) and (p < 0.02), alternatively. CONCLUSION: C. pneumoniae seropositivity in the rosacea patients and controls was insignificant. PMID:37200759 | PMC:PMC10186054 | DOI:10.4103/abr.abr_233_21 {url} = URL to article
    • Most Viewed FAQs List Guide  • Please note: If you click and receive a message that 'you do not have permission to view" that means you need to Join the RRDi to View ($2 minimum subscription). Maybe you have some of the same questions and want to do some research. That is what the RRDi is all about.  Below are the FAQs in the order of the most views as of February 2021:  Is this rosacea?  By far the most frequently asked question on the internet and on the RRDi website.  Are there any Oracea Anecdotal Reports? (New FAQ) Answer shows 81.6K views What about Mirvaso for rosacea? (New FAQ) Answer shows 23.6K views What is demodectic rosacea? (New FAQ) Answer shows 23.2K views What is the most viewed rosacea regimen on the RRDi website? (New FAQ) Answer shows 19.7K views What about Isotretinoin for Rosacea? (New FAQ) Answer shows 18.2K views Is Carbohydrate Essential For Human Survival? (New FAQ) Answer shows 16.4K views What about sugar and rosacea? (New FAQ) Answer shows 14.8K views What is Horse Paste for Rosacea? (New FAQ) Answer shows 13.5K views What about researching diet/lifestyle and rosacea? (New FAQ) Answer shows 13.4K views What does a dietician nutritionist have to say about rosacea? (New FAQ) Answer shows 13.1K views What is Steroid Rosacea? (New FAQ) Answer shows 12.1K views Why Form Another Non Profit Organization For Rosacea? (New FAQ) Answer shows 11.4K views Do Rosaceans Suffer from Nutritional Deficiencies? 959 views in FAQs (The answer shows 10.8K views) What is Seborrheic Dermatitis? (New FAQ) Answer shows 10.3K views What should a newbie rosacean learn about rosacea? (New FAQ) Answer shows 9.6K views What Prescription and Non Prescription Flushing Avoidance Treatments are there? (New FAQ) Answer shows 9.2K views What are the latest theories on the cause of rosacea? (New FAQ) Answer shows 9.1K views What about Antibiotic Resistance, Bacterial Overgrowth, Side Effects? (New FAQ) Answer shows 8.6K views Can Rosacea Go Into Remission? 7.5K views What rosacea trigger factors are there? (New FAQ) Answer shows 7.5K views What about NSAIDs For Rosacea? (New FAQ) Answer shows 7.4K views What is Oracea for rosacea? (New FAQ) Answer shows 7.2K views Does Yogurt Or Liver Trigger Rosacea? 3.1K views in FAQs (The article with the answer shows 7.2K views) Are there any Doxycycline Anecdotal Reports? (New FAQ) Answer shows 7.1K views Is the Subtype Classification Of Rosacea Controversial? (New FAQ) Answer shows 6.8K views What is Keratosis Pilaris Rubra Faceii (KPRF)? (New FAQ) Answer shows 6.6K views Do You Have A Gut Feeling About Your Rosacea? (New FAQ) Answer shows 6.5K views What full coverage make up foundation is for rosacea? (New FAQ) Answer shows 6.5K views) How do you make a home made ivermectin cream? (New FAQ) Answer shows 6.5K views) What about aspirin for rosacea? (New FAQ) Answer shows 6.4K views) Is Carbohydrate A Rosacea Trigger? (new FAQ) Answer shows 6.1K views What is Periorol Dermatitis? (New FAQ) Answer shows 6K views What cosmetics are there for rosacea? (New FAQ) Answers show 5.9K views What is the Innate Immune Response Disorder theory on rosacea? (New FAQ) Answers show 5.7K views Are there any Anecdotal Reports of Carbohydrate and Sugar Rosacea Trigger Avoidance? (New FAQ) Answers show 5.7K views Is Coffee A Rosacea Trigger? 5.6K views How is a Differential Diagnosis Of Rosacea Obtained? (New FAQ) Answer shows 5.6K views What is Keratosis Pilaris Rubra Faceii? (New FAQ) Answer shows 5.6K views Is Rosacea A ‘Complicated Diagnosis Path’ And Mysterious Disorder? (New FAQ) Answer shows 5.4K views What Sugars Should I Avoid to Control My Rosacea? (New FAQ) Answer shows 5.4K views What is the Ketamine 0.5% and Amitriptyline 1% Treatment for Rosacea? (New FAQ) Answer shows 5.4K views What about IBS and Rosacea? (New FAQ) Answer shows 5.4K views What is Gram-Negative Folliculitis? (New FAQ) Answer shows 5.3K views What is Neurogenic Rosacea? (New FAQ) Answer shows 5.3K views What about researching Gene therapy & Isolation of Rosacea Genes? (New FAQ) Answer shows 5.3K views What Should I Ask My Physician? 5K views What about Soolantra for rosacea? (New FAQ) Answer shows 5K views Does Vitamin B Complex Trigger Rosacea? 4.9K views What is Rosacea LTD-IV? (New FAQ) Answer shows 4.9K views What diet triggers rosacea? (New FAQ) Answer shows 4.9K views Is Lamb's Quarters A Rosacea Trigger? (New FAWQ) Answer shows 4.8K views What Is The World Wide Number Of Cases Of Rosacea? 4.6K views What is Telangiectasias (Phenotype 3)? (New FAWQ) Answer shows 4.6K views What is Granulomatous Rosacea? (New FAWQ) Answer shows 4.5K views What are some Treatments for Demodex Skin Mites? (New FAQ) Answer shows 4.4 views What is ZOSSO (aka ZZ Cream)? (New FAQ) Answer shows 4.4 views What is Rosacea Fulminans? (New FAQ) Answer shows 4.3 views  What is the Helicobacter Pylori Theory in Rosacea? (New FAQ) Answer shows 4.3 views  What about Zeloglin for rosacea? (New FAQ) Answer shows 4.3 views Rosacea or Demodex, Which Came First? (New FAQ) Answer shows 4.1 views What two rosacea mimics are called PF? (New FAQ) Answer shows 4.1 views Can You Get A Diagnosis For Rosacea On The Internet? 4K views What about SIBO and Rosacea? (New FAQ) Answer shows 4K views What are some Natural Treatments For Rosacea? (New FAQ) Answer shows 3.9K views Does IPL Kills Demodex Mites? (New FAQ) Answer shows 3.9K views What anti-flushing drugs for rosacea are there?  (New FAQ) Answer shows 3.9K views What about oral ivermectin for Rosacea? (New FAQ) Answer shows 3.7K views What about red clover for rosacea flushing? (New FAQ) Answer shows 3.7K views What is the GPSkin® Barrier Device for Rosacea? (New FAQ) Answer shows 3.6K views Does Aspirin Help for Rosacea Flushing? (New FAQ) Answer shows 3.6K views What about Psychology and Rosacea? (New FAQ) Answer shows 3.6K views What about low gastric acid and rosacea? (New FAQ) Answer shows 3.6K views What is an elimination diet? (New FAQ) Answer shows 3.5K views Is there more information on sugar and rosacea? (New FAQ) Answer shows 3.5K views How can I avoid blushing? (New FAQ) Answer shows 3.5K views What Is The Rosacea Butterfly Or T Zone? 3.4K views If My Rosacea Is Severe What Treatments Are Available? 3.4K views What is the difference between a Papule, Pustule, Pimple, Comedo, Lesion, Cyst? (New FAQ) Answers shows 3.4K views What is Pyoderma Faciale? (New FAQ) Answers shows 3.4K views What is Dr. Dray Anti-Redness Regimen? (New FAQ) Answers shows 3.4K views Is rosacea caused by bacteria? (New FAQ) Answers shows 3.4K views Is Rosacea Triggered By A Vitamin B Complex Supplement? (New FAQ) Answers shows 3.4K views What Causes Rosacea? 3.3K views (New FAQ) Answer shows 3.3K views What is Argan Organics anti redness + rosacea cream? (New FAQ) Answer shows 3.3K views Is Rosacea Caused by Genetics? (New FAQ) Answer shows 3.3K views What about Sodium Sulfacetamide - Sulfur for rosacea? (New FAQ) Answer shows 3.2K views What are some rosacea rare flareups? (New FAQ) Answer shows 3.2K views Is Sugar A Rosacea Trigger? 3.1 views What is the Gold Standard for Rosacea Treatment? (New FAQ) Answer shows 3.1K views What about Lutein with Zeaxanthin for Rosacea? (New FAQ) Answer shows 3.1K views What about metronidazole and rosacea? (New FAQ) Answer shows 3.1K views What about flushing and rosacea? (New FAQ) Answer shows 3.1K views Is Flushing Rosacea? 3K views Does Rosacea Progress In Stages? 3K views Do Acne Treatments Irritate Rosacea? 3K views What is Erysipelas? (New FAQ) Answer shows 2.9K views What about Immunosuppressants for rosacea? New FAQ) Answer shows 2.9K views What Is A Rosacea Trigger? 2.8K views What is the difference between a Variant, a Subtype and a Phenotype? New FAQ) Answer shows 2.8K views What is Gastrointestinal Rosacea [GR] (aka, Gut Rosacea)? (New FAQ) Answer shows 2.8K views Does a honey mask improve rosacea? (New FAQ) Answer shows 2.8K views What about Cathelicidin Peptide LL-37 and Vitamin D3 in rosacea? (New FAQ) Answer shows 2.8K views Is Rosacea Misdiagnosed? (New FAQ) Answer shows 2.7K views What is Erythromelalgia? (New FAQ) Answer shows 2.7K views What is the history of ivermectin? (New FAQ) Answer shows 2.7K views What is Lupoid Rosacea? (New FAQ) Answer shows 2.6K views Are Migraine Headaches Related To Rosacea? 2.5K views Can a doctor diagnose rosacea in five minutes or less? (New FAQ) Answer shows 2.5K views What is Eczema (Atopic Dermatitis)? (New FAQ) Answer shows 2.5K views What is Rosacea Conglobata? (New FAQ) Answer shows 2.5K views What is the Angiogenesis & VEGF theory on rosacea? (New FAQ) Answer shows 2.5K views How can I volunteer for the RRDi? (New FAQ) Answer shows 2.5K views Do any of the royal family in the UK have rosacea? (New FAQ) Answer shows 2.5K views Is Lupus a rosacea mimic? (New FAQ) Answer shows 2.4K views What is ProSkin Rosacea Natural Skin Cream by Mama Nature? (New FAQ) Answer shows 2.4K views What is Azelaic Acid for rosacea? (New FAQ) Answer shows 2.4K views Is Sugar Addictive? (New FAQ) Answer shows 2.4K views Has anyone committed suicide because of blushing? (New FAQ) Answer shows 2.4K views Is Flushing Rosacea? 2.4K views When posting on the RRDi website how can I balance Anonymity and Transparency? (New FAQ) Answer shows 2.4K views What rosacea panel recommended the phenotype classification? (New FAQ) Answer shows 2.4K views Can You Self Diagnose Rosacea? 2.3K views What is the X Factor in Rosacea? 2.3K views What is Glandular Rosacea? (New FAQ) Answer shows 2.3K views What is Low Dose Naltrexone for rosacea? (New FAQ) Answer shows 2.3K views Is Perioral Dermatitis a rosacea variant? (New FAQ) Answer shows 2.3K views What is Dermatomyositis? (New FAQ) Answer shows 2.3K views What does Cathelicidin have to do with rosacea? (New FAQ) Answer shows 2.2K views Does a vacation to the South Pacific which includes snorkeling improve rosacea? 2.1K views What If I Don't Want To Lose Weight Or I Need Carbohydrate For Athletics? 2.1K views What about LED for rosacea? (New FAQ) Answer shows 2.1K views What about Antibiotics For Rosacea? (New FAQ) Answer shows 2.1K views What about Rhofade for rosacea? (New FAQ) Answer shows 2.1K views How do you use the RRDi FAQs? 2.1K views What is the Autoimmune Protocol Diet? (New FAQ) Answer shows 2.1K views Will a Humidifier Help Rosacea? 2K views Are there any Demodex Mite Videos? (New FAQ) Answer shows 2K vews What is the difference between a rosacea flare up and flushing? 2K views What is the History of Demodectic Rosacea? (New FAQ) Answer shows 2K views What about ETS and rosacea? (New FAQ) Answer 2K views Is The Lymphatic System Involved With Rosacea? 1.9K views What is an Alternative to Soolantra's (Ivermectin) High Cost? (New FAQ) Answer shows 1.9K views What is Tranexamic Acid Solution for rosacea? (New FAQ) Answer shows 1.9K views What about MSM and Grapefruit Seed Extract for Rosacea? (New FAQ) Answer shows 1.9K views What is the Hanacure Face Mask? (New FAQ) Answer shows 1.9K views What brand of laser for rosacea? (New FAQ) Answer shows 1.8K views Are there any IPL Anecdotal Negative Reports? (New FAQ) Answer shows 1.8K views What do alarmins have to do with rosacea? (New FAQ) Answer shows 1.8K views What is the Rosacea Diet? (New FAQ) Answer shows 1.8K views Spicy Food A Rosacea Trigger? (New FAQ) Answer 1.8K views What Is An Elimination Diet? 1.7K views Does Lifestyle Effect Rosacea? 1.7K views What Non Prescription Treatments Are Available? 1.7K views Is Obesity A Factor In Rosacea? 1.7K views Does Coconut Oil Improve Rosacea? (New FAQ) Answer shows 1.7K views Are there any Laser Anecdotal Negative Reports? (New FAQ) Answer shows 1.7K views Is there a generic ivermectin cream?  (New FAQ) Answer shows 1.7K views Does Lifestyle Effect Rosacea? 1.7K views What are 7 Things Girls With Rosacea Are Tired Of Hearing? (New FAQ) Answer shows 1.7K views Will I Get Rhinophyma? 1.6K views What is sulfur butter for rosacea? (New FAQ) Answer shows 1.6K views What About Steroid Induced Rosacea? 1.6K views If you take Soolantra continuously does it get worse before it gets better? (New FAQ) Answer shows 1.6K views What about Fluorescent Lights (and other artificial lights) and rosacea? (New FAQ) Answer shows 1.6K views Does Sai Pallavi suffer from rosacea? (New FAQ) Answer shows 1.6K views Does Lex Gillies, Beauty Blogger Have Rosacea? (New FAQ) Answer shows 1.6K views Does Amy Schumer suffer from rosacea? (New FAQ) Answer shows 1.6K views Is Sofia Vergara “prone to rosacea”? (New FAQ) Answer shows 1.6K views What is the Antioxidant System Defect Hypothesis Theory in rosacea? (New FAQ) Answer shows 1.6K views What Prescription Treatments Are Prescribed For Rosacea? 1.5K view Is Rosacea A Genetic Disease Or Caused By The Environment? 1.5K views What are the Jennifer Brown Soolantra Videos? (New FAQ) Answer shows 1.5K views What about amberin for hot flashes? (New FAQ) Answer shows 1.5K views How can I post a review of an item in the RRDi affiliate store? (New FAQ) Answer shows 1.5K views Do Renee Zellweger and Cameron Diaz Both have Rosacea? (New FAQ) Answer shows 1.5K views What is radio frequency for rosacea? (New FAQ) Answer shows 1.4K views What is the difference between demodex, dust mites, bed bugs and scabies? (New FAQ) Answer shows 1.4K views What treatments are there for Phymatous (Rhinophyma) Phenotype 5? (New FAQ) Answer shows 1.4K views What is a rosacea mimic (video)? (New FAQ) Answer shows 1.4K views What is Kwellada-P Lotion for rosacea? (New FAQ) Answer shows 1.4K views What is IPL for rosacea? (New FAQ) Answer shows 1.4K views Are there other light devices for rosacea besides laser, LED and IPL? (New FAQ) Answer shows 1.4K views What about Oral Ivermectin Compared with Ivermectin–Metronidazole Combined Therapy? (New FAQ) Answer shows 1.4K views What about Melanotan (Afamelanotide) for rosacea? (New FAQ) Answer shows 1.4K views What does Chlamydophila Pneumoniae have to do with rosacea? (New FAQ) Answer shows 1.4K views How does the AARS spend its donations? (New FAQ) Answer shows 1.4K views (New FAQ) Answer shows 1.4K views Is there any treatment for rosacea that works on everyone? (New FAQ) Answer shows 1.4K views What about Rossoseq for Rosacea? (New FAQ) Answer shows 1.4K views Which Alcohol is Your Rosacea Trigger? 1.3K views What Natural Treatments Are There For Rosacea? 1.3K views What are some free or inexpensive treatments for rosacea? 1.3K views Is The Nervous System Involved With Rosacea? 1.3K views Is Rosacea Confusing, A Bewilderment And A Mystery? 1.3K views Do Children Get Rosacea? 1.3K views What About The Immune System Theory On Rosacea? 1.3K views What Is The Vascular Theory On Rosacea? 1.3K views What Bacteria Is Associated With Rosacea? 1.3K views What is Persistent Erythema ( Phenotype 2)? (New FAQ) Answer 1.3K views What is Avenova? (New FAQ) Answer 1.3K views Does Going to the Beach Improve Rosacea? (New FAQ) Answer 1.3K views What about Botox for Rosacea? (New FAQ) Answer 1.3K views What about Praziquantel for rosacea? (New FAQ) Answer 1.3K views How does the NRS spend its donations? (New FAQ) Answer 1.3K views What are the steps to receive a free RRDi G Suite account?  (New FAQ) Answer 1.3K views What is Medscape Clinical Advances in Rosacea? (New FAQ) Answer 1.3K views Does William Shatner suffer from rosacea? (New FAQ) Answer 1.3K views Did Rembrandt suffer from rosacea? (New FAQ) Answer 1.3K views What about Multistat® For Treatment Of Rosacea? (New FAQ) Answer 1.3K views What about Multistat® For Treatment Of Rosacea? (New FAQ) Answer 1.3K views Can Rosacea be Cured? 1.2K views What is Nu-Stock? (New FAQ) Answer shows 1.2K views Demodex Density Count - What are the Numbers? (New FAQ) Answer shows 1.2K views What is Arquebusade Herbal Water for Rosacea? (New FAQ) Answer shows 1.2K views Is Carbohydrate a Rosacea Trigger? 1.2K views Do You Have A Gut Feeling? 1.2K views What does Tom Busby have to say about ocular rosacea (phenotype 6)? (New FAQ) Answer shows 1.2K views What is broad band light for rosacea?  (New FAQ) Answer shows 1.2K views What about Brimonidine for rosacea? (New FAQ) Answer shows 1.2K views What about Taurine Bromamine for rosacea? (New FAQ) Answer shows 1.2K views What does Propionibacterium Acnes have to do with rosacea? (New FAQ) Answer shows 1.2K views Name Five Five Celebrities with Rosacea? (New FAQ) Answer shows 1.2K views Does William Clinton suffer from rosacea? (New FAQ) Answer shows 1.2K views Who is the rosacea poster boy? (New FAQ) Answer shows 1.2K views Does Infrared Sauna Hurt or Help Rosacea? (New FAQ) Answer shows 1.2K views Does Kristin Chenoweth Have Rosacea? (New FAQ) Answer shows 1.2K views What About Candida Albicans And Rosacea? 1.1K views What Is The Inflammatory Theory On Rosacea? 1.1K views What is Halogen rosacea? (New FAQ) Answer 1.1K views  What is the Ivermectin for Rosacea Horse Paste Poll? (New FAQ) Answer 1.1K views What is Cat's Claw for Rosacea? (New FAQ) Answer 1.1K views What Is PDT? 1.1K views What are some treatments for Phenotype 2? (New FAQ) Answer 1.1K views What is the Thoemmes Demodex DNA Test? (New FAQ) Answer 1.1K views What is Endothelyol for Erythematotelangiectatic Rosacea? (New FAQ) Answer 1.1K views What Light Devices are available for rosacea? (New FAQ) Answer 1.1K views How do you wash off Soolantra? (New FAQ) Answer 1.1K views Do Anti-Anxiety Prescriptions Improve Rosacea? (New FAQ) Answer 1.1K views What is Nonpathogenic E. coli strain Nissle 1917 in Probiotics? (New FAQ) Answer 1.1K views What is Rosacea Beyond the Visible? (New FAQ) Answer 1.1K views Is the painting in the Lourve, The Old Man and His Grandson Phenotype 5? (New FAQ) Answer 1.1K views Can I join the RRDi with just an email address? (New FAQ) Answer 1.1K views How is rosacea research compared with other skin conditions? (New FAQ) Answer 1.1K views Is this rosacea? 1K views Is there a steroid rosacea video? (New FAQ) Answer shows 1K views Does Salvia hispanica kills mites in 7 minutes? (New FAQ) Answer shows 1K views What About H Pylori And Rosacea? 1K views What about alcohol and rosacea? 1K views What about Plaquenil (Hydroxychloroquine) for Rosacea? (New FAQ) Answer shows 1K views Does Levothyroxine ( L-thyroxine) Exacerbates Rosacea? (New FAQ) Answer shows 1K views What about Caper Extract Cream for Rosacea? (New FAQ) Answer shows 1K views Who do Male Patients With Telangiectasia, Rosacea Tend To Wait To Seek Treatment? (New FAQ) Answer shows 1K views What are the benefits of volunteering for the RRDi? (New FAQ) Answer shows 1K views What is the difference between acne and rosacea? 943 views What about florescent lights and rosacea? 943 views What is the Rosacea Rescue Web Site? (New FAQ) Answer shows 935 views What do demodex mites have to do with rosacea? 927 views What Rosacea Treatment And Skin Care Tips Are Available? 911 views What Microorganisms Have Been Associated With Rosacea? 878 views What Oxidative Stress, Ferritin and Rosacea? (New FAQ) Answer shows 844 views What About Accutane For Rosacea? 839 views Does treatment for rosacea usually gets worse before it gets better? (New FAQ) Answer shows 837 views Can Rosacea Be Misdiagnosed? 826 views What About Demodex Mites And Rosacea? 821 views Who is Amelia Fais Harnas and her Art, Wine, & Rosacea? (New FAQ) Answer shows 817 views What is Rosacea? - Talk with Neal Schultz, MD 812 views Can Rosacea Co-Exist With Other Skin Conditions? 800 views What is Bionect Cream for rosacea? (New FAQ) Answer shows 780 views Is Rosacea Contagious? 773 views What's The Difference Between A Subtype And A Variant Of Rosacea? 772 views How Do I Deal With Rosacea Emotionally? 760 views What About Steroids For Rosacea? 744 views Can You Use the Skin Microbiome to Clear Rosacea? (New FAQ) Answer shows 721 views What is a Grassroots Rosacea Non Profit? (New FAQ) Answer shows 719 views What Is Neurogenic Rosacea? 717 views Any tips for reducing or preventing flushing or flare ups caused by exercise? 716 views What is a grassroots non profit organization for rosacea? (New FAQ) Answer shows 711 views What Anti-Flushing Drugs Are Available? 707 views What about Callistemon Viminalis for rosacea? (New FAQ) Answer shows 703 views What about Quassia amara for rosacea? (New FAQ) Answer shows 699 views What is the Placebo/Nocebo Effect in Rosacea? (New FAQ) Answer shows 676 views What skin conditions mimic rosacea? (New FAQ) Answer shows 672 views What is the Bradykinin Rosacea Theory? (New FAQ) Answer shows 672 views How do I submit an article to the RRDi? (New FAQ) Answer shows 659 views Does rosacea spread beyond the facial region? 654 views Who funds most rosacea research? (New FAQ) Answer shows 632 views What are blood filled cysts? 590 views Is there a Holistic Approach to Rosacea? (New FAQ) Answer shows 589 views What is a simple method to control rosacea? (New FAQ) Answer shows 576 views Is the Epidermal Barrier Dysfunction something to consider? (New FAQ) Answer shows 555 views What does rosacea look like? 550 views What is Rosacea? 534 views Who are some famous rosaceans? 534 views What is the Butterfly Effect in Rosacea? 519 views Does Rosacea Cause Emotional Pain? (New FAQ) Answer shows 516 views What is it about demodex mites that may trigger rosacea? (New FAQ) Answer shows 516 views Can I create my own free rosacea blog? (New FAQ) Answer shows 506 views What are 13 questions proposed by two rosacea researchers? (New FAQ) Answer shows 492 views What are some Topical Probiotic Treatments for Rosacea? (New FAQ) Answer shows 472 views What about HLA-DRA Locus and Rosacea? (New FAQ) Answer shows 451 views What about Rosacea and Glioma? (New FAQ) Answer shows 441 views What is causing the rosacea fire in our diet? (New FAQ) Answer shows 433 views Is the Epidermal Barrier Dysfunction something to consider? (New FAQ) Answer shows 433 views What is the Skin Barrier Integrity with Fatty Acids Theory? (New FAQ) Answer shows 426 views What is Rosacea Rebound? 418 views What about Artemesinin for Rosacea? (New FAQ) Answer shows 408 views What about IBD and Rosacea? (New FAQ) Answer shows 407 views Why is the phenotype classification superior to the subtype classification? 405 views What about depression and rosacea? (New FAQ) Answer shows 405 views When treating rosacea is more or less better? (New FAQ) Answer shows 395 views How do contraceptives effect rosacea? 394 views What do Cytokines have to do with Rosacea? (New FAQ) Answer shows 388 views Are Peer Reviewed Papers the Gold Standard? (New FAQ) Answer shows 388 views How much does the American Academy of Dermatologists spend on research? (New FAQ) Answer shows 385 views What Moisturizer for Rosacea? 370 views What is radiofrequency for rosacea? 370 views Where have all the rosaceans gone? (New FAQ) Answer shows 354 views What does Cathlecidin have to do with rosacea? 348 views What is ImageJ for Rosacea Research? (New FAQ) Answer shows 344 views What is the Risk-benefit Ratio in Rosacea Research & Development? (New FAQ) Answer shows 339 views How Many Skin Types? Renée Rouleau Says Nine Types! 335 views Do more women or men have rosacea? 326 views What is the difference between a Trigger, a Tripwire, a Flareup, and a Flush? 298 views Is Folliculitis a Rosacea Mimic? (New FAQ) Answer shows 262 views What is the difference between sensitive skin and rosacea? (New FAQ) Answer shows 226 views What would you prefer rosacea research to be focused on? 226 views Is Rosacea Associated with Other Diseases? 216 views How does Phenotype Classification work? (New FAQ) Answer shows 214 views How Can I Reduce Large Pores? 190 views What Oral Treatments for Rosacea Are Available? 164 views What about Raynaud syndrome and Rosacea? (New FAQ) Answer shows 158 views Do Dermatological Textbooks have any Conflict of Interests? (New FAQ) Answer shows 142 views How can I win a free jar of the ZZ cream? (New FAQ) Answer shows 101 views Will Rosacea Develop into Phenotype 5 - Phymatous? 19 views What does Staphylococcus epidermidis have to do with rosacea? (New FAQ) Answer shows 17 views Does the skin industry use social media to advertise? (New FAQ) Answer shows 10 views What if I want to volunteer for the RRDi as Grant Writer? (New FAQ) 4 views
    • Curr Issues Mol Biol. 2023 Mar 24;45(4):2703-2716. doi: 10.3390/cimb45040177. ABSTRACT Rosacea is a chronic inflammatory skin disease whose late manifestations have not yet been clearly reported in animal models. The objective of this study is to describe the skin lesions and major histopathological changes in a rosacea-like phenotype in mice induced by prolonged LL-37 administration and furthermore, to assess the potential of long-term LL-37 administration in inducing irreversible rosacea-like skin lesion models. Balb/c mice were continuously injected intradermally with LL-37 every 12 h to induce a rosacea-like phenotype. After LL-37 injections were administered for 20 consecutive days, the area of rosacea-like lesions gradually expanded in the first 13 days, then entered a stable phase. Haematoxylin and eosin (H&E) and Van Gieson's staining showed a high degree of inflammatory cell aggregation, thickening of the epidermis and dermis, and collagen deposition in large quantities. The results of immunofluorescence staining and Western blotting showed that the expression of α-SMA, TNF-α, vimentin, and COL1 in the skin of mice was significantly upregulated. Short-term LL-37 administration induced rosacea-like lesions that only featured the aggregation of inflammatory factors and thickening of the epidermis, whereas no collagen hyperplasia was observed, and a full recovery was noticed. However, rosacea-like skin lesions induced by long-term LL-37 administration did not completely recover. Our study compares rosacea-like lesions induced by short-term versus long-term LL-37 administration, and the results suggest that irreversible rosacea-like lesions can be induced by long-term LL-37 administration. PMID:37185701 | PMC:PMC10136735 | DOI:10.3390/cimb45040177 {url} = URL to article
    • Georgian Med News. 2023 Mar;(336):66-72. ABSTRACT Rosacea is a chronic, inflammatory skin disorder that adversely affects patients' life quality. The aim of the study was to evaluate the quality of life (QoL) and to find the connection between QoL and coping strategies in the patients suffering from rosacea. A total of 138 patients, aged from 22 to 80, took part in this research with the first-time confirmed diagnosis of rosacea. All patients completed the Dermatology Life Quality Index (DLQI) questionnaire in order to evaluate the patients' attitudes to the impact of rosacea on QoL and Coping Strategies Questionnaires (COPE). The study has determined that Average DLQI in the case of rosacea equals 14.09+3.18. Mean Rosacea-Specific DLQI is symptoms and feelings - 3.75+1.92, daily activities - 3.12+1.77; leisure - 2.52+1.81, work and/or school - 1.52+1.50, personal relationships - 2.42+1.90, treatment - 1.59+1.04. The usage of instrumental social support - 3.39 has the highest score factor in the COPE questionnaire. Rosacea has a strong impact on human life. QoL in rosacea patients is connected to such factors as age, gender, employment status, self-esteem, and subtype of the disease. Correlation analysis shows the connection between the quality of life and coping strategy. Based on the recession analysis formula, the large and extremely large effect of DLQI can be calculated according to the existing risk consequently, the results obtained in our study may be a kind of starting point for the elaboration of complex support for patients with rosacea. PMID:37166883 {url} = URL to article
    • Curr Med Chem. 2023 May 8. doi: 10.2174/0929867330666230508141434. Online ahead of print. ABSTRACT Statins are HMG-CoA reductase inhibitors and decrease plasma low-density lipoprotein cholesterol (LDL-C) levels. They are well tolerated, and because of their LDL-C-lowering effect, they are utilized to decrease the risk of atherosclerosis and cardiovascular disease. However, statins have pleiotropic effects, including immunomodulatory, anti-inflammatory, antioxidant, and anticancer. Currently, oral administration is the only Food and Drug Administration (FDA)-approved route of administration for statins. However, other administration routes have demonstrated promising results in different pre-clinical and clinical studies. For instance, statins also seem beneficial in dermatitis, psoriasis, vitiligo, hirsutism, uremic pruritus, and graft-versus-host disease. Topically applied statins have been studied to treat seborrhea, acne, rhinophyma, and rosacea. They also have beneficial effects in contact dermatitis and wound healing in animal studies, (HIV) infection, osseointegration, porokeratosis, and some ophthalmologic diseases. Topical and transdermal application of statins is a non-invasive drug administration method that has shown significant results in bypassing the first-pass metabolism in the liver, thereby reducing possible adverse effects. This study reviews the multifaceted molecular and cellular impacts of statins, their topical and transdermal application, novel delivery systems, such as nanosystems for topical and transdermal administration and the challenges concerning this approach. PMID:37157198 | DOI:10.2174/0929867330666230508141434 {url} = URL to article
    • Skinmed. 2023 May 9;21(2):110-111. eCollection 2023. ABSTRACT EpsolayTM cream is a novel topical treatment that utilizes microencapsulated benzoyl peroxide to treat moderate to severe papulopustular rosacea. It is effective at decreasing, and for some patients clearing, the papules, pustules, and telangiectasias associated with rosacea. It is well-tolerated with minimal adverse effects and has demonstrated efficacy comparable to other topical agents that are used for the condition. PMID:37158351 {url} = URL to article
    • Am J Clin Dermatol. 2023 May 9. doi: 10.1007/s40257-023-00777-5. Online ahead of print. ABSTRACT BACKGROUND: Although lesion counting is an evaluation method that effectively analyzes facial acne severity, its usage is limited because of difficult implementation. OBJECTIVES: We aimed to develop and validate an automated algorithm that detects and counts acne lesions by type, and to evaluate its clinical applicability as an assistance tool through a reader test. METHODS: A total of 20,699 lesions (closed and open comedones, papules, nodules/cysts, and pustules) were manually labeled on 1213 facial images of 398 facial acne photography sets (frontal and both lateral views) acquired from 258 patients and used for training and validating algorithms based on a convolutional neural network for classifying five classes of acne lesions or for binary classification into noninflammatory and inflammatory lesions. RESULTS: In the validation dataset, the highest mean average precision was 28.48 for the binary classification algorithm. Pearson's correlation of lesion counts between algorithm and ground-truth was 0.72 (noninflammatory) and 0.90 (inflammatory), respectively. In the reader test, eight readers (100.0%) detected and counted lesions more accurately using the algorithm compared with the reader-alone evaluation. CONCLUSIONS: Overall, our algorithm demonstrated clinically applicable performance in detecting and counting facial acne lesions by type and its utility as an assistance tool for evaluating acne severity. PMID:37160644 | DOI:10.1007/s40257-023-00777-5 {url} = URL to article
    • Ital J Dermatol Venerol. 2023 Apr;158(2):110-116. doi: 10.23736/S2784-8671.23.07484-4. ABSTRACT While rosacea is a common dermatologic condition, ocular rosacea is sometimes evident either with cutaneous rosacea or occasionally by itself. Manifesting with such varied symptoms as dry eye, Meibomian gland dysfunction, and corneal erosion, ocular rosacea can be confused with a multitude of other diseases. While ocular rosacea is commonly mild and rarely severe, physicians should still expand their examination to include ocular manifestations of rosacea. In addition, we propose diagnostic criteria for ocular rosacea, stressing the importance of early recognition and treatment. PMID:37153945 | DOI:10.23736/S2784-8671.23.07484-4 {url} = URL to article
    • Eur J Dermatol. 2023 Feb 1;33(1):6-11. doi: 10.1684/ejd.2023.4405. ABSTRACT BACKGROUND: Rosacea prevalence varies worldwide and there is a lack of information in Brazil. OBJECTIVES: To describe the epidemiological profile of rosacea in subjects who consulted in dermatological outpatient clinics in Brazil. MATERIALS & METHODS: A cross-sectional study was conducted in 13 dermatological outpatient clinics across the country. Patients with rosacea diagnosis were eligible for the study according to the investigator's clinical assessment. Clinical, social and demographic data were collected. The overall and regional rosacea prevalence was calculated, and association with baseline characteristics was analysed. RESULTS: A total of 3,184 subjects were enrolled, and rosacea prevalence was 12.7%. The southern region of Brazil presented a higher prevalence, followed by the southeast. The subjects in the rosacea group were older than those without rosacea (52.5 ±14.9 vs. 47.5 ±17.5; p<0.001). Moreover, the rosacea group was associated with Fitzpatrick's phototypes I and II, Caucasian ethnicity, a family history of rosacea, and facial erythema, however, no association with gender was found. The most prevalent clinical sign and clinical subtype in rosacea patients were erythema and erythematotelangiectatic, respectively. CONCLUSION: Rosacea is highly prevalent in Brazil, mostly in the southern region, associated with phototypes I and II and a family history. PMID:37154809 | DOI:10.1684/ejd.2023.4405 {url} = URL to article
    • Int Immunopharmacol. 2023 May 5:110233. doi: 10.1016/j.intimp.2023.110233. Online ahead of print. NO ABSTRACT PMID:37150709 | DOI:10.1016/j.intimp.2023.110233 {url} = URL to article
    • Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(4. Vyp. 2):36-43. doi: 10.17116/jnevro202312304236. ABSTRACT OBJECTIVE: Development of a clinical typology of nosogenic psychosomatic disorders in patients with skin diseases. MATERIAL AND METHODS: The study was carried out in the interclinical psychosomatic department of the Clinical Center and the Clinic of Skin and Venereal Diseases named after. V.A. Rakhmanov Sechenov University in 2007 to 2022. Nine hundred and forty-two patients (253 males, 689 females, average age 37.3±12.4 years) with nosogenic psychosomatic disorders in chronic dermatoses, including ichen planus (n=143), psoriasis (n=137), atopic dermatitis (n=132), acne (n=118), rosacea (n=115), eczema n=10), seborrheic dermatitis (n=88), vitiligo (n=52), pemphigus (n=48), were studied. Index of clinical symptoms (ICS); the Dermatology Quality of Life Index (DQLI); itching severity questionnaire - Behavioral rating scores (BRS); the Hospital Anxiety and Depression Scale (HADS) and statistical methods were used. RESULTS: In patients with chronic dermatoses, nosogenic psychosomatic disorders were diagnosed according to ICD-10 criteria within adaptation disorders [F43.8] (n=465; 49.3%); hypochondriacal disorder [F45.2] (n=235; 24.9%); constitutionally determined and acquired (hypochondriac development) personality disorders [F60] (n=118; 12.5%); schizotypal disorder [F21] (n=65; 6.9%); recurrent depressive disorder [F33] (n=59; 6.2%). A typological model of nosogenic disorders in dermatology has been developed: hypochondriacal nosogenies in severe clinical forms of dermatosis (pemphigus, psoriasis, lichen planus, atopic dermatitis, eczema) and dysmorphic nosogenies in objectively mild, but cosmetically significant forms of dermatosis (acne, rosacea, seborrheic dermatitis, vitiligo). When analyzing socio-demographic and psychometric indicators, significant differences were revealed between the selected groups (p<0.001). In turn, the selected groups of nosogenic disorders demonstrate significant clinical heterogeneity and include various types of nosogenies that form a unique palette of the nosogenic spectrum in the structure of an extensive psychodermatological continuum. Along with the severity of the skin process, the dominant role in the formation of the clinical picture of nosogeny, including cases of paradoxical dissociation of the quality of life with the severity of dermatosis, amplification and somatization of itching, has a premorbid personality structure and somatoperceptive accentuation of the patient, as well as the presence of a comorbid mental disorder. CONCLUSION: The typology of nosogenic psychosomatic disorders in patients with skin diseases requires consideration of both the psychopathological structure of the disorders under discussion and the severity/clinical features of the skin process. PMID:37141127 | DOI:10.17116/jnevro202312304236 {url} = URL to article
    • Br J Dermatol. 2023 May 4:ljad148. doi: 10.1093/bjd/ljad148. Online ahead of print. ABSTRACT BACKGROUND: Vitiligo is an autoimmune skin disorder characterized by loss of melanocytes. Protease-mediated disruption of junctions between keratinocytes and/or keratinocyte intrinsic dysfunction may directly contribute to melanocyte loss. House dust mite (HDM), an environmental allergen with potent protease activity, contributes to respiratory and gut disease but also to atopic dermatitis and rosacea. OBJECTIVE: To verify if HDM can contribute to melanocyte detachment in vitiligo and if so, by which mechanism(s). METHODS: Using primary human keratinocytes, human skin biopsies from healthy and vitiligo patients, and 3D reconstructed human epidermis, we studied the effect of HDM on cutaneous immunity, tight and adherent junction expression and melanocyte detachment. RESULTS: HDM increased keratinocyte production of vitiligo-associated cytokines and chemokines and increased expression of TLR-4. This was associated with increased in situ MMP-9 activity, reduced cutaneous expression of adherent protein E-cadherin, increased soluble E-cadherin in culture supernatant and significantly increased number of supra-basal melanocytes in the skin. This effect was dose-dependent and driven by cysteine protease Der p1 and MMP-9. Selective MMP-9 inhibitor, Ab142180 restored E-cadherin expression and inhibited HDM-induced melanocyte detachment. Keratinocytes from vitiligo patients were more sensitive to HDM-induced changes than healthy keratinocytes. All results were confirmed in 3D model of healthy skin and in human skin biopsies. CONCLUSIONS: Our results highlight that environmental mite may act as an external source of PAMPs in vitiligo and topical MMP-9 inhibitors may be useful therapeutic targets. Whether HDM contributes to onset of flares in vitiligo remains to be tested in carefully controlled trials. PMID:37140010 | DOI:10.1093/bjd/ljad148 {url} = URL to article
    • Exp Dermatol. 2023 May 4. doi: 10.1111/exd.14830. Online ahead of print. ABSTRACT Common skin disorders such as acne vulgaris, rosacea and folliculitis are bothersome prevalent inflammatory diseases of hair follicles that can easily be investigated bedside using optical coherence tomography (OCT) and reflectance confocal microscopy (RCM) with micrometre resolution, opening a novel era for high-resolution hair follicle diagnostics and quantitative treatment evaluation. EMBASE, PubMed and Web of Science were searched until 5 January 2023 to identify all studies imaging hair follicle characteristics by RCM and OCT for diagnosis and monitoring of treatment in hair follicle-based skin disorders. This study followed PRISMA guidelines. After inclusion of articles, methodological quality was assessed using the QUADAS-2 critical appraisal checklist. Thirty-nine in vivo studies (33 RCM and 12 OCT studies) were included. The studies focused on acne vulgaris, rosacea, alopecia areata, hidradenitis suppurativa, folliculitis, folliculitis decalvans, lichen planopilaris, discoid lupus erythemasus, frontal fibrosing alopecia and keratosis pilaris. Inter- and perifollicular morphology including number of demodex mites, hyperkeratinization, inflammation and vascular morphology could be assessed by RCM and OCT in all included skin disorders. Methodological study quality was low, and interstudy outcome variability was high. Quality assessment showed high or unclear risk of bias in 36 studies. Both RCM and OCT visualize quantitative features as size, shape, content and abnormalities of hair follicles, and have potential to support clinical diagnosis and evaluate treatment effects. However, larger studies with better methodological quality are needed to implement RCM and OCT directly into clinical practice. PMID:37140216 | DOI:10.1111/exd.14830 {url} = URL to article
    • J Cosmet Dermatol. 2023 May 2. doi: 10.1111/jocd.15747. Online ahead of print. ABSTRACT BACKGROUND: Since there is currently no conclusion on the efficacy and adverse effects of oxymetazoline, this meta-analysis attempts to explore its efficacy and adverse events, so as to provide guidance for clinical medication. METHODS: We searched PubMed, Embase, and Cochrane Library from the establishment of the database to May 2021. We included studies that patients were randomly assigned to receive oxymetazoline or vehicle, and we excluded duplicate publications, research without full text, incomplete information or inability to conduct data extraction, animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data. RESULTS: The pooled results show that the 3 (RR = 1.76, 95% CI: 1.53-2.03), 6 (RR = 1.71, 95% CI: 1.47-2.00), 9 (RR = 1.63, 95% CI: 1.40-1.90), 12 (RR = 1.41, 95% CI: 1.18-1.67) -hours CEA success rate and the 3 (RR = 1.65, 95% CI: 1.34-2.03), 6 (RR = 1.75, 95% CI: 1.43-2.14), 9 (RR = 1.63, 95% CI: 1.33-2.00), 12 (RR = 1.78, 95% CI: 1.45-2.18) -hours SSA success rate after oxymetazoline treatment for rosacea is significantly higher than that of vehicle. Additionally, the pooled results show that the incidence of TEAEs after treatment with oxymetazoline is significantly higher than that of vehicle (RR = 1.34, 95% CI: 1.10-1.2). However, our analysis of specific adverse events found that the oxymetazoline group was only significantly higher than the vehicle group in the incidence of application-site dermatitis (RR = 8.91, 95% CI: 1.76-45.23), and there was no statistical significance in the difference in the incidence of other adverse events. CONCLUSION: Oxymetazoline is effective and can be selected for the treatment of persistent facial erythema of rosacea. Additionally, application-site dermatitis was the most important one. PMID:37128814 | DOI:10.1111/jocd.15747 {url} = URL to article
    • Int J Mol Sci. 2023 Apr 10;24(8):7021. doi: 10.3390/ijms24087021. ABSTRACT Under physiological conditions, skin mast cells play an important role as guardians that quickly react to stimuli that disturb homeostasis. These cells efficiently support, fight infection, and heal the injured tissue. The substances secreted by mast cells allow for communication inside the body, including the immune, nervous, and blood systems. Pathologically non-cancerous mast cells participate in allergic processes but also may promote the development of autoinflammatory or neoplastic disease. In this article, we review the current literature regarding the role of mast cells in autoinflammatory, allergic, neoplastic skin disease, as well as the importance of these cells in systemic diseases with a pronounced course with skin symptoms. PMID:37108184 | DOI:10.3390/ijms24087021 {url} = URL to article
    • Int J Mol Sci. 2023 Apr 11;24(8):7053. doi: 10.3390/ijms24087053. ABSTRACT Lipidomics is a term used to define the field that analyzes the structure, functions, and interactions of lipids. Inflammatory dermatoses and lipid disturbances are interrelated, especially due to chronic inflammatory conditions. This review discusses lipidomics in selected inflammatory skin diseases: psoriasis, lichen planus, and atopic dermatitis, as well as the less commonly mentioned hidradenitis suppurativa, rosacea, and acne vulgaris. Lipid homeostasis disorders are common; they are especially well-documented in psoriasis, lichen planus, and atopic dermatitis. Future studies are required for better insight into this issue, particularly on the skin lipidome. Understanding lipidomics, in particular skin diseases, increases our knowledge about their pathogenesis, and may become useful in adjusting tailored management for each patient as well establishing prognosis. Noteworthily, it seems advisable to alert doctors to the need to analyze lipid parameters and the complications of abnormal lipid metabolism in dermatological patients, which could decrease their comorbidities and improve the life quality and health condition of dermatological patients. PMID:37108216 | DOI:10.3390/ijms24087053 {url} = URL to article
    • Exp Dermatol. 2023 Apr 28. doi: 10.1111/exd.14823. Online ahead of print. ABSTRACT The translatability of research is highly dependent on models that recapitulate human tissues and organs. Here, we describe a procedure for the generation of human epidermis organotypic cultures (HEOCs) from primary keratinocytes isolated from foreskin and adult skin as well as from an immortalized keratinocyte cell line (KerTr). We tested several media conditions to develop a defined HEOC growing and expansion media. We characterized the HEOCs and show that in optimal culture conditions they express the proliferation marker Ki67, the basement membrane protein collagen 17 (col17) and the epidermal differentiation markers keratin 15 (K15), keratin 14 (K14), keratin 5 (K5), keratin 10 (K10), keratin 1 (K1), transglutaminase 1 (TGM1), transglutaminase 3 (TGM3) and filaggrin (FLG). Thus, they recapitulate the human epidermis and are stratified from the basal layer to the stratum corneum. These HEOC can be generated reproducibly on a large scale, making it an invaluable model for screening therapeutic compounds and also for the study of pathologies affecting the epidermis. PMID:37114406 | DOI:10.1111/exd.14823 {url} = URL to article
    • Ophthalmologie. 2023 Apr 27. doi: 10.1007/s00347-023-01863-z. Online ahead of print. ABSTRACT Overall, conjunctival scarring is rare and often overlooked during routine examination. However, the differential diagnostic distinction of cicatricial mucous membrane pemphigoid from other causes is crucial for further treatment planning. Other entities that lead to conjunctival scarring, are ocular rosacea, ocular graft-versus-host disease, atopic keratoconjunctivitis, infections, trauma and further sometimes very rare diseases. Most of these differential diagnoses have in common that conjunctival scarring does not progress indefinitely if untreated, in contrast to mucous membrane pemphigoid. PMID:37106092 | DOI:10.1007/s00347-023-01863-z {url} = URL to article
    • You are spot on with your comment. Just need someone like you to post some more and engage as a volunteer to implement your insight into all this. Change your membership status from inactive to active, which would be helpful. 
    • Just an update on your financial situation. We were able to continue with Invision Community for our website, but this has depleted our  donations to just $152.86 at the end of March. Not sure if we can continue unless we get 100 active subscribers which would keep us going. Donations in 2022 including subscriptions totaled $357.94. Expenses in 2022 amounted to $415.82.   We also need some active subscribers who post as well as any volunteers who would like to serve on the board of directors. Could you  post in this thread your thoughts on whether you think the RRDi should keep going or not?  In order to post in this thread you will need to join the RRDi. If you want to volunteer to serve on the board of directors please post why and what you would do to make the RRDi an active non profit organization for rosacea sufferers.  This final appeal has been going on now since June 2021 and we scrapped by with just barely covering our expenses to keep this non profit organization going. It is estimated that in 2023 we will need at least $1K in donations to keep going. Subscriptions help but we simply don't have enough subscribers to meet our expenses. Here is a list of the major expenses:  Invision Community website forum  Registering our domains  Apple Developer account (to be able to use Sign in with Apple  If you want all the details of our financial situation, click here. 
    • Exp Dermatol. 2023 Apr 23. doi: 10.1111/exd.14820. Online ahead of print. ABSTRACT Recent data indicate that distinct skin areas show different microbial/chemical milieu. Keratinocytes (KC) respond to these stimuli by producing cytokine mediators. Therefore, we aimed to determine KC-derived cytokine expression in distinct healthy skin regions (gland-poor [GP], sebaceous gland-rich [SGR] and apocrine gland-rich [AGR]), and their changes in skin diseases of the given regions (atopic dermatitis [AD], papulopustular rosacea [PPR] and psoriasis). Cytokines were analysed at the mRNA and protein levels, and literature analysis was performed for functional categorization. The three regions showed characteristically different cytokine patterns. GP was featured by an IL-25/IL-33/IL-36RA/IL-38/IL-18 cytokine milieu, SGR was characterized by IL-23/IL-17C/IL-18, and AGR skin exhibited a mixed IL-25/IL-33/IL-23/IL-18 profile. Literature analyses revealed different homeostatic and proinflammatory roles of these cytokine patterns (Th2 related in GP, Th17 related in SGR and mixed Th2/Th17 in AGR). In skin diseases which are primarily epidermal cytokine-driven (AD, PPR), the level of the regionally characteristic cytokines were further elevated, in contrast to the autoantigen-driven psoriasis, where the cytokine pattern was independent from the localization. Healthy skin regions are equipped with different KC-derived cytokine profiles, which may influence each region's capability of mediator production in certain types of dermatoses. PMID:37088961 | DOI:10.1111/exd.14820 {url} = URL to article
    • Can J Ophthalmol. 2023 Apr 20:S0008-4182(23)00108-4. doi: 10.1016/j.jcjo.2023.03.020. Online ahead of print. ABSTRACT PURPOSE: To describe clinical features and management of toxic keratoconjunctivitis associated with punctal and (or) canaliculus stenosis (toxic soup syndrome). DESIGN: Retrospective observational case series. METHODS: Electronic medical record database search for the keywords "toxic soup syndrome" and retrospective chart review were performed. Thirty-five eyes of 25 patients were seen at a tertiary cornea clinic between January 2017 and December 2021. Sex, age, distance-corrected visual acuity, topical medications, symptoms, clinical signs, and outcomes after medical and surgical interventions were analyzed. The main outcome measured was improvement in ocular surface signs and symptoms after interventions. RESULTS: Overall, 35 eyes of 25 patients with a mean age of 66.8 ± 12.8 years, of which 72% were female, were included. The primary complaint was hyperemia and epiphora in all patients. Rosacea or meibomian gland disease were present in all patients, 7 (28%) had glaucoma, and 7 (28%) developed limbal stem cell deficiency. Twenty-two patients (88%) were using topical medications on presentation. All eyes had either punctal plugs, cauterized puncta, or punctal and (or) canaliculus stenosis. Management of all patients consisted of suspension of all preserved topical medications and institution of some type of anti-inflammatory therapy. Nineteen patients (76%) improved after improvement of lacrimal drainage. One patient with severe resistance in the canaliculus required ongoing preservative-free topical steroids. CONCLUSIONS: Chronic drug-induced or pooled inflammatory mediators causing toxic conjunctivitis may be aggravated by punctal and (or) canaliculus stenosis, leading to toxic soup syndrome. Clearance of punctal obstruction leads to improvement in most patients. PMID:37088101 | DOI:10.1016/j.jcjo.2023.03.020 {url} = URL to article
    • Exp Dermatol. 2023 Apr 22. doi: 10.1111/exd.14812. Online ahead of print. ABSTRACT Rosacea is a complex chronic inflammatory skin disorder with high morbidity. Pyroptosis is known as a regulated inflammatory cell death. While its association with immune response to various inflammatory disorders is well established, little is known about its functional relevance of rosacea. So, we aimed to explore and enrich the pathogenesis involved in pyroptosis-related rosacea aggravations. In this study, we evaluated the pyroptosis-related patterns of rosacea by consensus clustering analysis of 45 ferroptosis-related genes (FRGs), with multiple immune cell infiltration analysis to identify the pyroptosis-mediated immune response in rosacea using GSE65914 dataset. The co-co-work between PRGs and WGCNA-revealed hub genes has established using PPI network. FRG signature was highlighted in rosacea using multi-transcriptomic and experiment analysis. Based on this, three distinct pyroptosis-related rosacea patterns (non/moderate/high) were identified, and the notably enriched pathways have revealed through GO, KEGG and GSEA analysis, especially immune-related pathways. Also, the XCell/MCPcount/ssGSEA/Cibersort underlined the immune-related signalling (NK cells, Monocyte, Neutrophil, Th2 cells, Macrophage), whose hub genes were identified through WGCNA (NOD2, MYD88, STAT1, HSPA4, CXCL8). Finally, we established a pyroptosis-immune co-work during the rosacea aggravations. FRGs may affect the progression of rosacea by regulating the immune cell infiltrations. In all, pyroptosis with its mediated immune cell infiltration is a critical factor during the development of rosacea. PMID:37086043 | DOI:10.1111/exd.14812 {url} = URL to article
    • J Cosmet Dermatol. 2023 Apr 18. doi: 10.1111/jocd.15758. Online ahead of print. NO ABSTRACT PMID:37073424 | DOI:10.1111/jocd.15758 {url} = URL to article
    • Dermatol Reports. 2022 Jul 7;15(1):9526. doi: 10.4081/dr.2022.9526. eCollection 2023 Mar 7. ABSTRACT Coronavirus disease 2019 is a severe acute respiratory syndrome, and wearing a mask is an important preventive measure. However, long-term use can cause maskne, or mask-induced acne. This study evaluated the prevalence, clinical characteristics, and severity of mask-induced acne and its effect on pre-existing dermatosis using an online questionnaire. The questionnaire comprised 15 questions on 6 primary topics: demographic data, type of face mask, dermatological symptoms after using a mask, preexisting dermatological conditions, the duration of use, and the effects of mask use on existing dermatological conditions. We included 1,025 participants; 48.6% had dermatological symptoms after using masks. The most common symptoms were red papules (33.8%) and itching (27.2%). Individuals who wore masks for more than 4 hours daily experienced more dermatological symptoms, for example, healthcare providers, who had a higher risk of maskrelated dermatosis than participants with other occupations. Moreover, masks significantly increased the severity of rosacea, contact dermatitis, and seborrheic dermatitis. These results suggest that board-certified dermatologists should assess patients in larger-scale studies to determine adequate management strategies. PMID:37063397 | PMC:PMC10099290 | DOI:10.4081/dr.2022.9526 {url} = URL to article
    • Dermatol Reports. 2022 Jul 6;15(1):9511. doi: 10.4081/dr.2022.9511. eCollection 2023 Mar 7. ABSTRACT Irregularities of vitamin levels are being increasingly identified associated with skin conditions, and systemic and topical therapies have shown promising improvements. There have been some remarkable improvements achieved, but large variations in outcomes suggest that these conditions are not simply related to a single deficiency or solved by providing a single supplement. Cyanocobalamin, pyridoxine (B6) and riboflavin (B2) supplementation were linked with exacerbating existing acne. There were also reports of allergic reactions to parenteral cobalamin including acne, rosacea, allergic site reactions or anaphylaxis with cobalamin injections. This was also reported in patients who had allergic contact dermatitis to cobalt, where cobalamin therapy resulted in cutaneous manifestations such as chronic vesicular hand dermatitis, cheilitis and stomatitis. The use of niacinamide in acne vulgaris as an alternative to clindamycin or adjunct is also notable, as well as its application for hyperpigmentation. Vitamin B3 also has promise in chemoprevention in particular nonmelanoma skin cancer prophylaxis. Folic acid has a developing role in psoriasis. The data for vitiligo remains inconclusive. Assessment for potential vitamin deficiency, particularly B vitamins, should form part of the normal work-up for a wide range of skin conditions. PMID:37063401 | PMC:PMC10099312 | DOI:10.4081/dr.2022.9511 {url} = URL to article
    • Cureus. 2023 Mar 15;15(3):e36177. doi: 10.7759/cureus.36177. eCollection 2023 Mar. ABSTRACT Introduction Mucocutaneous complications in kidney transplant patients are due to drug toxicity or immunosuppression. The main objective of our study was to determine the risk factors associated with their occurrence. Methods We conducted a prospective analytical study (January 2020- June 2021) including kidney transplant patients seen at the Nephrology Department. We described the characteristics of the patients who presented mucocutaneous complications and then compared them to those who didn't to deduce the risk factors. Statistical analysis was performed using SPSS 20.0 (p<0.05). Results Of the 86 patients recruited, thirty patients had mucocutaneous complications. The mean age was 42.73, with a male predominance (73%). Ten kidney transplants were performed from a living-related donor. All the patients received corticosteroids, Mycophenolate Mofetil, and the Calcineurin Inhibitor: Tacrolimus (76.7%) or Ciclosporin (23.3%). Induction was performed with Thymoglobulin (n=20) or Basiliximab (n=10). Mucocutaneous complications were dominated by infectious manifestations (53.4%): eight cases of fungal infections; six cases of viral infections: warts (n=3), herpes labialis (n=2), intercostal herpes zoster (n=1), and two cases of bacterial infections: atypical mycobacteria and boils. Inflammatory complications (36.6%) included acne (n=4), urticaria (n=3), rosacea (n=1), simple maculopapular exanthema (n=1), aphthous lesion (n=1), and black hairy tongue (n=1). Actinic keratosis, skin xerosis, and bruises were found in one patient respectively. The evolution with a symptomatic treatment was good in all the patients. After statistical analysis, the factors significantly associated with the occurrence of mucocutaneous complications were advanced age, male gender, anemia, HLA non-identical donor, as well as the use of Tacrolimus or Thymoglobulin. Conclusion Infectious mucocutaneous complications are the most common dermatological manifestations among renal transplant recipients. Their occurrence is related to advanced age, male gender, anemia, HLA non-identical donor, and the use of Tacrolimus or Thymoglobulin. PMID:37065336 | PMC:PMC10103621 | DOI:10.7759/cureus.36177 {url} = URL to article
    • J Am Acad Dermatol. 2023 Apr 15:S0190-9622(23)00595-9. doi: 10.1016/j.jaad.2023.04.010. Online ahead of print. NO ABSTRACT PMID:37068661 | DOI:10.1016/j.jaad.2023.04.010 {url} = URL to article
    • J Cosmet Dermatol. 2023 Apr 16. doi: 10.1111/jocd.15779. Online ahead of print. NO ABSTRACT PMID:37062760 | DOI:10.1111/jocd.15779 {url} = URL to article
    • Arch Dermatol Res. 2023 Apr 16. doi: 10.1007/s00403-023-02621-6. Online ahead of print. ABSTRACT Morbihan disease (MD) is considered a rare complication of rosacea, which is difficult to diagnose and challenging to treat. Here, we performed a systematic review of available case reports and case series to summarize key clinical and pathologic features of and successful treatment regimens for MD. We conducted a search of the PubMed/MEDLINE, EMBASE, and Cochrane electronic databases from their inception to the date of search on March 6, 2023. We found that MD affects patients in the fifth decade of life on average, more commonly reported in male than female (69% vs 31%). Clinically, MD affects the eyelids, cheeks, and forehead most commonly, presenting as non-pitting, erythematous edema or an edematous plaque. On biopsy, the pathologic features, such as dermal edema, sebaceous hyperplasia, perivascular and periadnexal inflammatory infiltrate, and granulomatous reaction, are frequently reported. Out of 55 patients who were able to achieve complete response without recurrence, 35% of patients were treated with isotretinoin and 22% were treated with tetracycline antibiotics with a daily dosage range of 20-80 mg and 40-200 mg, respectively. Out of those 55 patients, 22% and 7% were treated successfully with surgical intervention and intralesional injection of steroids, respectively. Additionally, lymphatic drainage has been shown to be an effective adjunctive therapeutic tool. More studies are necessary to understand the disease mechanism to improve the diagnosis of and develop evidence-based therapies for MD. PMID:37062777 | DOI:10.1007/s00403-023-02621-6 {url} = URL to article
    • J Am Acad Dermatol. 2023 Apr 13:S0190-9622(23)00637-0. doi: 10.1016/j.jaad.2023.03.055. Online ahead of print. NO ABSTRACT PMID:37061134 | DOI:10.1016/j.jaad.2023.03.055 {url} = URL to article
    • Chin Med J (Engl). 2023 Apr 17. doi: 10.1097/CM9.0000000000002496. Online ahead of print. NO ABSTRACT PMID:37057731 | DOI:10.1097/CM9.0000000000002496 {url} = URL to article
    • Skin Therapy Lett. 2023 Mar;28(2):6-9. ABSTRACT Virtually any antibiotic can be used in dermatology given the broad range of conditions treated. With the widespread use of antibiotics and the rapid emergence of resistant organisms, it is important to understand how dermatologists can combat this issue. PMID:37054726 {url} = URL to article
    • Ophthalmic Epidemiol. 2023 Apr 9:1-7. doi: 10.1080/09286586.2023.2199838. Online ahead of print. ABSTRACT PURPOSE: To identify factors associated with chalazion diagnosis and surgical excision. METHODS: Patients with an incident chalazion diagnosis from 2002 to 2019 were compared 1:5 with matched controls. Multivariable logistic regression was performed to identify variables associated with diagnosis and surgical excision. RESULTS: Chalazion patients (n = 134,959) and controls (678,160) were analyzed. Risk factors for diagnosis included female sex, non-white race, northeast location, conditions affecting periocular skin and tear film (blepharitis, meibomian gland dysfunction, rosacea, pterygium), non-ocular inflammatory conditions (gastritis, inflammatory bowel disease, sarcoidosis, seborrheic dermatitis, Graves' disease), and smoking (p < .001 for all comparisons). Thirteen percent of patients with chalazion underwent subsequent surgical excision. Diabetes and systemic sclerosis diagnoses decreased odds of diagnosis (p < .001). Male sex, rosacea diagnosis, Black and Hispanic race, antibiotic use, and doxycycline use increased odds of surgery (p < .001). CONCLUSION: Female sex, non-white race, conditions affecting periocular skin and the tear film, several non-ocular inflammatory conditions, and smoking were risk factors for chalazion diagnosis. Male sex, rosacea diagnosis, Black and Hispanic race, antibiotic use, and doxycycline use were risk factors for surgical intervention for chalazion. Our results prompt further study of these variables and their relationship to chalazion diagnosis to understand physiology and improve clinical outcomes. Furthermore, the results of this study suggest early recognition and treatment of concomitant rosacea may serve an important role in the management of chalazion and in the prevention of surgical intervention. PMID:37032590 | DOI:10.1080/09286586.2023.2199838 {url} = URL to article
    • Indian J Ophthalmol. 2023 Apr;71(4):1382-1390. doi: 10.4103/IJO.IJO_2983_22. ABSTRACT Rosacea is a chronic, inflammatory facial dermatosis commonly found in fair skin tone population. Recent studies have shown the increasing prevalence in the dark skin tone population as well. Ocular involvement is very common and can occur without cutaneous features. Common ocular features are chronic blepharoconjunctivitis with eyelid margin inflammation and meibomian gland dysfunction. Corneal complications include corneal vascularization, ulceration, scarring, and rarely, perforation. Diagnosis is largely based on clinical signs, although it is often delayed in the absence of cutaneous changes, particularly in children. The management ranges from local therapy to systemic treatment, depending on the severity of the disease. There is a positive association between demodicosis and rosacea; however, causality is always argued. In this review, we describe the epidemiology, clinical features, and treatment of rosacea and ocular rosacea. PMID:37026270 | DOI:10.4103/IJO.IJO_2983_22 {url} = URL to article
    • J Am Acad Dermatol. 2023 Apr 4:S0190-9622(23)00531-5. doi: 10.1016/j.jaad.2023.03.042. Online ahead of print. NO ABSTRACT PMID:37024052 | DOI:10.1016/j.jaad.2023.03.042 {url} = URL to article
    • J Dermatol. 2023 Apr 5. doi: 10.1111/1346-8138.16767. Online ahead of print. ABSTRACT The pathogenesis of granulomatous rosacea (GR), the only variant of rosacea, is unclear. To investigate the differences between GR and non-granulomatous rosacea (NGR) in clinical characteristics, histopathological changes and gene expression for the purpose of providing new ideas on the pathogenesis of rosacea. A total of 30 GR and 60 NGR patients were included. Their clinical and histopathological information was collected retrospectively, and the characteristics of immune cell infiltration were investigated by multiple immunohistochemical staining. RNA sequencing and transcriptome analysis were performed on three pairs of skin samples from GR and NGR patients, respectively. Then, the expressions of candidate genes that were potentially associated with granuloma formation were verified by immunohistochemical staining. It was found that GR patients were more prone to the occurrence of rosacea in the forehead, periocular and perioral skin (p = 0.001, p < 0.001, p = 0.001), and presented more severe papules and pustules when compared with NGR patients (p = 0.032). For histopathological features, the inflammatory cells primarily infiltrated around hair follicles in the GR group and around blood vessels in the NGR group. In addition, the neutrophils were richer (p = 0.036) and the expression levels of CD4+ , CD8+ and CD68+ cells were higher (p = 0.047, p < 0.001, p < 0.001) in the GR group than in the NGR group. In addition, the GR group had apparent collagen hyperplasia (p = 0.026). A total of 420 differentially expressed genes (DEGs) were detected, and bioinformatics analysis showed that the DEGs were enriched in neutrophil activation, adaptive immune response and other biological processes. Lastly, the candidate genes related to neutrophil activation and collagen hyperplasia, i.e., Cathepsin S (CTSS), Cathepsin Z (CTSZ) and matrix metalloproteinases 9 (MMP9), were confirmed to be highly expressed in the GR group. The clinical and histopathological features of GR exhibited a very diverse pattern compared with NGR, and the underlying mechanisms may be related to neutrophil activation and collagen hyperplasia. PMID:37020415 | DOI:10.1111/1346-8138.16767 {url} = URL to article
    • J Osteopath Med. 2023 Mar 31. doi: 10.1515/jom-2023-0052. Online ahead of print. NO ABSTRACT PMID:36998111 | DOI:10.1515/jom-2023-0052 {url} = URL to article
    • Int Immunopharmacol. 2023 Mar 27;118:110057. doi: 10.1016/j.intimp.2023.110057. Online ahead of print. ABSTRACT BACKGROUND: Rosacea is a chronic inflammatory skin disease with immunological dysfunction. Supramolecular salicylic acid (SSA) has the properties of keratolytic, antibacterial, and anti-inflammatory. However, the mechanism of SSA in the treatment of rosacea is still unclear. OBJECTIVE: To investigate the efficiencies and molecular mechanisms of SSA in rosacea. METHODS: Forty mice were randomly divided into four groups (10 in each group): control, LL-37, LL-37 + azelaic acid (AzA), and LL-37 + SSA. Forty μl LL-37 (320 μM) was administered intradermally into the dorsal skin of the mice in the latter 3 groups every 12 h and 4 times altogether (0 h, 12 h, 24 h, 36 h). Twenty % AzA was applied on the eruptions after the first and third LL-37 injection (0 h, 24 h) in LL-37 + AzA group, while 30 % SSA was applied after the first injection (0 h) in LL-37 + SSA group. The redness score and redness area were evaluated. The skin barrier function was measured by the transepidermal water loss (TEWL) and pH. The infiltration of inflammatory cells was evaluated by hematoxylin-eosin staining, and the inflammatory biomarkers were analyzed by RT-PCR and immunohistochemistry. RESULTS: SSA alleviated LL-37-induced rosacea-like inflammation. The increased TEWL and pH induced by LL-37 were also reversed by SSA. In addition, SSA reduced inflammatory cell infiltration and suppressed the production of Toll-like receptor 2, Matrix metallopeptidase 9, kallikrein 5, LL-37 associated with rosacea, and inhibited LL-37-induced NOD-like receptor family, pyrin domain containing 3 (NLRP3)-mediated inflammasome activation in mice. CONCLUSIONS: Our findings indicated that SSA ameliorated LL-37-induced rosacea-like lesions by suppressing NLRP3-mediated inflammasome activation in mice. PMID:36989903 | DOI:10.1016/j.intimp.2023.110057 {url} = URL to article
    • J Cosmet Dermatol. 2023 Mar 28. doi: 10.1111/jocd.15728. Online ahead of print. NO ABSTRACT PMID:36977653 | DOI:10.1111/jocd.15728 {url} = URL to article
    • J Eur Acad Dermatol Venereol. 2023 Mar 27. doi: 10.1111/jdv.19062. Online ahead of print. ABSTRACT BACKGROUND: Acne vulgaris provides a unique disease setting in which a prominent skin inflammation is coupled with the overproduction of lipid-rich sebum. OBJECTIVES: Our goal was to evaluate the expression of barrier molecules in papular acne skin samples obtained from untreated patients and compare those to the results of healthy and of papulopustular rosacea-involved ones at the mRNA and protein levels. In addition, we aimed to assess the effects of various sebum-composing lipids on the expression of proteins involved in barrier formation in keratinocytes. METHODS: Available microarray datasets of papular acne and papulopustular rosacea-affected skin samples were reanalyzed with a focus on epidermal barrier-related pathways. Immunohistochemistry was performed to detect barrier molecules in the interfollicular regions of human acne and healthy skin samples. Protein levels of barrier-related genes were measured by Western blot in samples of HaCaT keratinocytes treated with selected lipids. RESULTS: Meta-analysis of whole transcriptome datasets revealed that barrier-related pathways are significantly affected in acne vulgaris skin samples. While an altered expression of key molecules in maintaining barrier functions such as filaggrin, keratin 1, involucrin, desmoglein 1, kallikrein 5 and 7, was also observed at the protein levels. Our data demonstrated that sebum composing lipids may selectively modify the levels of epidermal barrier-related molecules. CONCLUSIONS: Our results suggest that although not as prominently as in the dry papulopustular rosacea skin, the epidermal barrier in the interfollicular region may be damaged also in the lipid-rich skin samples of papular acne. Furthermore, our findings indicating diverse regulatory effects of various sebum lipids on the expression of barrier molecules in keratinocytes suggest, that they may influence the moisturization of the skin as well. Altogether, our findings could have implications in the development of sebum-modulating anti-acne therapies and even in the care of symptom-free skin. PMID:36971768 | DOI:10.1111/jdv.19062 {url} = URL to article
    • Ophthalmic Plast Reconstr Surg. 2023 Mar 27. doi: 10.1097/IOP.0000000000002380. Online ahead of print. ABSTRACT This is a case report of a single patient who had pulsed dye laser and hybrid fractional laser treatments for facial rosacea and subsequently developed a prolonged papular reaction in and adjacent to the area of treatment, which was unresponsive to topical therapy. Biopsies of these lesions revealed necrotizing granulomas. This is a previously unreported side effect of these laser treatments and clinicians should be aware of this potential sequela. PMID:36972126 | DOI:10.1097/IOP.0000000000002380 {url} = URL to article
    • Front Pharmacol. 2023 Mar 1;14:1092473. doi: 10.3389/fphar.2023.1092473. eCollection 2023. ABSTRACT Background: Rosacea is a common facial skin inflammatory disease featured by hyperactivation of mTORC1 signaling in the epidermis. Due to unclear pathogenesis, the effective treatment options for rosacea remain limited. Methods: Weighted gene co-expression network analysis (WGCNA) analyzed the relationship between epidermis autophagy and mTOR pathways in rosacea, and further demonstrated it through immunofluorescence and qPCR analysis. A potential therapeutic agent for rosacea was predicted based on the key genes of the WGCNA module. In vivo and in vitro experiments were conducted to verify its therapeutic role. Drug-target prediction (TargetNet, Swiss, and Tcmsp) and molecular docking offered potential pharmacological targets. Results: WGCNA showed that epidermis autophagy was related to the activation of mTOR pathways in rosacea. Next, autophagy was downregulated in the epidermis of rosacea, which was regulated by mTOR. In addition, the in vivo experiment demonstrated that autophagy induction could be an effective treatment strategy for rosacea. Subsequently, based on the key genes of the WGCNA module, epigallocatechin-3-gallate (EGCG) was predicted as a potential therapeutic agent for rosacea. Furthermore, the therapeutic role of EGCG on rosacea was confirmed in vivo and in vitro. Finally, drug-target prediction and molecular docking revealed that AKT1/MAPK1/MMP9 could be the pharmacological targets of EGCG in rosacea. Conclusion: Collectively, our findings revealed the vital role of autophagy in rosacea and identified that EGCG, as a therapeutic agent for rosacea, attenuated rosacea-like inflammation via inducing autophagy in keratinocytes. PMID:36937834 | PMC:PMC10014537 | DOI:10.3389/fphar.2023.1092473 {url} = URL to article
    • Cureus. 2023 Feb 15;15(2):e35011. doi: 10.7759/cureus.35011. eCollection 2023 Feb. ABSTRACT The most common cutaneous manifestations of alcoholism include urticarial reaction, flushing, porphyria cutanea tarda, psoriasis, rosacea, seborrheic dermatitis, and pruritus. Here, we present a case of a young male with a history of alcohol abuse who presented with non-blanching, petechial, and perifollicular macular rash secondary to vitamin C deficiency in view of poor oral intake. The rash improved significantly with vitamin C supplementation. Although rare in developed countries, clinicians should keep vitamin C deficiency as a differential diagnosis for skin rash in alcohol consumers. PMID:36938293 | PMC:PMC10021349 | DOI:10.7759/cureus.35011 {url} = URL to article
    • J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16779. Online ahead of print. ABSTRACT Symptomatic dermographism (SD) is the most common form of chronic inducible urticarias. The etiology of this disease has rarely been reported in the literature. Minocycline is widely used in the treatment of acne, rosacea, and other inflammatory skin diseases. Herein we report four cases of SD onset during minocycline administration. These were young women in their 20s to 30s who were taking minocycline orally for acne vulgaris or rosacea. They all experienced the onset of SD 2-3 weeks after taking the drug, and then the complete disappearance of SD 1 month after stopping the drug. Minocycline was thought to be the culprit drug in these cases as other drugs were ruled out on clinical grounds. Our small series suggests that oral minocycline may induce SD, thus raising the awareness of this association in clinical practice. More research is needed to further confirm this association and reveal the underlying mechanism(s). PMID:36938687 | DOI:10.1111/1346-8138.16779 {url} = URL to article
    • Arch Dermatol Res. 2023 Mar 20. doi: 10.1007/s00403-023-02602-9. Online ahead of print. ABSTRACT Individuals with rosacea have different facial erythema distribution patterns; however, whether they are related to the skin type is unclear. This study enrolled 201 Chinese patients, including 195 females and six males, diagnosed with rosacea. Facial images were taken using the VISIA® Complexion Analysis System, and red-area images were further analyzed. The erythema distribution pattern of rosacea was divided into peace signs, wing shapes, and neither of the two patterns, according to the distribution location. Skin types were divided according to the Fitzpatrick skin type, and oily-dry skin subtypes were determined according to the Baumann skin-type scale. There were 130 and 44 cases of typical peace signs and typical wing shapes, respectively. The remaining 27 cases were of neither type. Among the 76 patients with peace-sign patterns, the majority (58.5%) had oily combination skin. Among the patients with a typical wing shape, 43 (97.7%) had dry combination skin. Among the 27 patients with no peace-sign or wing-shape pattern, 17 (63.0%) had dry combination skin (p < 0.05). The peace sign pattern was more common in individuals with darker skin tones (p < 0.05). The differences in the immune microenvironment, Demodex habitation, and altered lipid content may explain the presence of the peace-sign pattern in the oily combination skin population. Wing-type patterns are associated with the lateral parts of the cheeks and could be caused by abnormal vessel dilations of the anatomic branches of the zygomatic-facial and facial arteries, which indicates that the main pathogenesis for this type of rosacea may be neurovascular. Our study is the first to report that facial erythema distribution characteristics of rosacea are associated with skin types. PMID:36939880 | DOI:10.1007/s00403-023-02602-9 {url} = URL to article
×
×
  • Create New...

Important Information

Terms of Use